Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

0
Number of overlapping holdings
0.0%
% of MEDX's 32 holdings also in PPH
nan%
% of PPH's 26 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in PPH |
Overlap |
---|
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PPH
ELI LILLY & CO | 11.7% | |
ABBVIE INC | 6.2% | |
NOVARTIS AG-ADR | 5.5% | |
AMGEN INC | 5.2% | |
BRISTOL-MYERS SQUIBB CO | 5.1% | |
JOHNSON & JOHNSON | 5.1% | |
ASTRAZENECA PLC-SPONS ADR | 4.7% | |
PFIZER INC | 4.6% | |
CRISPR THERAPEUTICS AG | 4.4% | |
BIOGEN IDEC INC | 4.2% |
MEDX Underweight Relative to PPH
2SEVENTY BIO, INC. | 0.2% | |
VIATRIS, INC. | 0.2% | |
ALLOGENE THERAPEUTICS, INC. | 0.3% | |
GE HEALTHCARE TECHNOLOGIES INC. | 0.4% | |
VANDA PHARMACEUTICALS INC | 0.5% | |
GALECTIN THERAPEUTICS INC | 0.6% | |
LANTERN PHARMA, INC. | 0.7% | |
REPLIMUNE GROUP, INC. | 0.9% | |
INTELLIA THERAPEUTICS, INC. | 1.6% | |
EDITAS MEDICINE, INC. | 1.9% |